Navigation Links
A London effort to develop point-of-care nanosensors for HIV diagnosis and monitoring
Date:4/6/2009

The London Centre for Nanotechnology will develop a new device to enable people living with HIV to monitor their own health and the effectiveness of their treatments, thanks to a 2 million EPSRC (Engineering and Physical Sciences Research Council) grant announced today.

The device will give people a way to monitor the virus for themselves, reducing the need to visit a doctor as often. It will act as an early warning system to tell patients to seek medical help if the virus is resisting anti-retroviral treatments. It could also be of real benefit to doctors in developing countries who urgently need rapid and affordable ways to diagnose and monitor their patients.

Researchers from the London Centre for Nanotechnology, a joint venture between UCL (University College London) and Imperial College London, and their research partners have been awarded the Nanotechnology for Healthcare grant from the EPSRC's Grand Challenge Competition.

The research will bring biomedical engineers, physicists, chemists, virologists and clinicians together to create the device, which will work in a similar way to how diabetics check their insulin levels - where a hand-held machine analyses a finger prick of blood.

The device will use tiny mechanical sensors, called nano-cantilever arrays, to measure HIV and other protein markers that can indicate a rise in the level of the virus and the body's response to it.

UCL lead investigator Dr Rachel McKendry, Reader in Biomedical Nanoscience at the LCN, explains: "The nano-cantilever arrays are each coated with substances that stick to the HIV and other proteins, which are markers associated with disease progression. Accommodating these markers causes the highly sensitive sensors to bend like a diving board and this bend indicates the level of virus in the body. We have used nano-cantilever arrays to investigate drug resistance in super bugs, and are excited by the opportunity to extend this approach to detecting HIV markers."

The device will display messages on an integral screen, giving patients access to clear, immediate advice. For example, they could be told that their condition remains stable if levels of virus do not change, or they could be told to make an appointment to see their doctor if the virus begins to flare up.

Investigator, Dr. Anna-Maria Goretti, an NHS consultant and co-investigator based at the Royal Free Hospital, says: "If patients neglect to take their treatments or need prompting to see their GP the device will provide a simple way of letting them know. It will really empower HIV patients to keep a close eye on their health and their treatments."

Robin Weiss, Professor of Viral Oncology at UCL, whose pioneering work in identifying the receptor for HIV has deepened our understanding of HIV/AIDS, adds: "One of the principal advantages of the proposed device is its capacity to monitor viral and immunological markers on a single chip without the need for time consuming analysis that requires specialist laboratories."

Dr Yeong-Ah Soh, lead investigator at Imperial and lecturer in Materials Science, who is responsible for engineering the nano-cantilever arrays, sayss: "This project combines technology from semiconductor processing with modern biology to produce a unique piece of kit for tracking how HIV develops in individual patients, and helping them to keep a close eye on their own health."

The project will be carried out over the next three years, with the promise of additional funding.

In the UK, there are an estimated 70,000 carriers of HIV. Worldwide, HIV/AIDS has grown to pandemic proportions and today there are 35 million people living with the virus, two-thirds of them in sub-Saharan Africa. This development is expected to bring major improvement to UK patient and will anchor UK at the forefront of HIV research.


'/>"/>

Contact: Dr Thierry Bontoux
t.bontoux@ucl.ac.uk
44-020-767-90056
University College London
Source:Eurekalert

Related biology news :

1. KAUST announces academic excellence alliance partnership with Imperial College London
2. Right whale sedation enables disentanglement effort
3. USC researchers head global effort to study genetic risks that contribute to psychiatric diseases
4. Endangered sawfish focus of national collection and recovery efforts
5. NIST, NCI bring web 2.0 tools to nanotechnology standards effort
6. Wake Forest plays integral role in effort to revolutionize vehicle safety
7. Corporate Safe Specialists Launches International Sales Efforts
8. Recovery efforts not enough for critically endangered Asian vulture
9. Scientists to assess Beijing Olympics air pollution control efforts
10. Scripps scientists will assess Beijing Olympics air pollution control efforts
11. Extended cyclone relief efforts aided from space
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2016)... November 22, 2016 According to the new market ... Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact ... MarketsandMarkets, the market is expected to grow from USD 10.74 Billion in ... 16.79% between 2016 and 2022. Continue Reading ... ...
(Date:11/21/2016)... , Nov. 21, 2016   Neurotechnology ... object recognition technologies, today announced that the MegaMatcher ... cards was submitted for the NIST Minutiae ... passed all the mandatory steps of the evaluation ... is a continuing test of fingerprint templates used ...
(Date:11/17/2016)... -- Global Market Watch: Primarily supported by ownership ... and Academics) market is to witness a value of US$37.1 ... highest Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen ... period 2014-2020. North America is not ... Europe at 9.56% respectively. Report Focus: ...
Breaking Biology News(10 mins):
(Date:12/4/2016)... ... December 03, 2016 , ... Microbial genomics leader ... grant award has been made to Dr. Renato Polimanti of Yale University School ... the oral microbiome. Grant proposals have been vetted by the company’s scientific review ...
(Date:12/2/2016)...  The Multiple Myeloma Research Foundation (MMRF) today announced ... SM —the largest and most comprehensive study driving new ... be presented at the 58 th American Society ... San Diego from December 3-6. The ... well as identify pathways and targets for new drug ...
(Date:12/2/2016)... San Antonio Texas (PRWEB) , ... ... ... announced today that it will share findings demonstrating the value of DNA ... cancer patients at this year’s San Antonio Breast Cancer Symposium. Using molecular ...
(Date:12/2/2016)... , ... December 01, 2016 , ... ... long-term client Nanowear on their recent FDA Class II 510(k) clearance for their ... significant hurdle in commercializing remote cardiac monitoring devices that rely on cloth-based nanosensors. ...
Breaking Biology Technology: